Work

Abstract P2-09-15: A phase I study of interferon-gamma (γ)plus weekly paclitaxel, trastuzumab and pertuzumab in patients with HER-2 positive breast cancer

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs18-p2-09-15

Authors: HS Han, H Khong, R Costa, L Loftus, D Goodridge, T Henry, H Soliman, R Ismail-Khan, B Fridley, B Czerniecki

Institution: Moffitt Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2944233883

Cites:

Cited by: 5

Related to: 10